Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
暂无分享,去创建一个
G. Guillon | M. Corbani | P. Gaudard | P. Colson | A. Virsolvy | A. Charrabi | S. Richard | M. Manière